Tag Professor Michal Lotem

24 Jul

Hadassah Cancer Research Institute: Groundbreaking Advance in Personalised Cancer Care

Hadassah Cancer Research Institute (HCRI), a leading force in advancing cancer treatments, unveils a significant breakthrough in personalised cancer care.   This research, published in the esteemed journal Cell Reports Medicine (June 11, 2024), introduces MESiCA, a novel machine learning model poised to revolutionise cancer diagnosis and treatment.   Professor Michal Lotem, Head of HCRI […]

READ MORE